EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer’s disease

Ningwei Wang, Wenlong Jia, Junqin Wang, Zejun Yang, Yaoyang Liu, Dehua Huang, Xiaohan Mei, Xinxin Xiong, Jing Shi, Yadong Tang, Guang Chen, Donghua Di und 2 weitere

Bioorganic Chemistry · 2024-02 · 143 · 107010

DOI: 10.1016/j.bioorg.2023.107010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024-02. Verfasst von Ningwei Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, 103 Wenhua Road, Shenhe Dist…. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss and deficits in cognitive domains. Low choline levels, oxidative stress, and neuroinflammation are the primary mechanisms implicated in AD progression. Simultaneous inhibition of acetylcholinesterase (AChE) and reactive oxygen species (ROS) production by a single molecule may provide a new breath of hope for AD treatment. Here, we describe donepezil-tacrine hybrids as inhibitors of AChE and ROS. Four series of derivatives with a β-amino alcohol linker were designed and synthesized. In this study, the target compounds were evaluated for their ability to inhibit AChE and butyrylcholinesterase (BuChE) in vitro, using tacrine (hAChE, IC50 = 305.78 nM; hBuChE, IC50 = 56.72 nM) and donepezil (hAChE, IC50 = 89.32 nM; hBuChE, IC50 = 9137.16 nM) as positive controls. Compound B19 exhibited an excellent and balanced inhibitory potency against AChE (IC50 = 30.68 nM) and BuChE (IC50 = 124.57 nM). The cytotoxicity assays demonstrated that the PC12 cell viability rates of compound B19 (84.37 %) were close to that of tacrine (87.73 %) and donepezil (79.71 %). Potential therapeutic effects in AD were evaluated using the neuroprotective effect of compounds against H2O2-induced toxicity, and compound B19 (68.77 %) exhibited substantially neuroprotective activity at the concentration of 25 μM, compared with the model group (30.34 %). Furthermore, compound B19 protected PC12 cells from H2O2-induced apoptosis and ROS production. These properties of compound B19 suggested that it was a multi-functional agent with AChE inhibition, anti-oxidative, anti-inflammatory activities, and low toxicity and that it deserves further investigation as a promising agent for AD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuroprotective AgentsAnimalsRatsTacrineDonepezilButyrylcholinesteraseCholinesterase InhibitorsAcetylcholinesteraseHydrogen PeroxideReactive Oxygen SpeciesMolecular Docking SimulationStructure-Activity Relationship

Stichwörter der Autor:innen

Alzheimer's diseaseCholinesterase inhibitorsDonepezilLow-toxicityTacrine

Substanzen

TacrineDonepezilButyrylcholinesteraseCholinesterase InhibitorsAcetylcholinesteraseHydrogen PeroxideReactive Oxygen SpeciesNeuroprotective Agents

Autor:innen und Institutionen

  • Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, 103 Wenhua Road, Shenhe District, Shenyang 110016, PR China; School of Pharmaceutical Engineering,…
  • School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, PR China.
  • School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenhe District, Shenyang 110016, PR China.

Zitieren

APA

Wang, N., Jia, W., Wang, J., Yang, Z., Liu, Y., Huang, D., Mei, X., Xiong, X., Shi, J., Tang, Y., Chen, G., Di, D., Hou, Y., & Liu, Y. (2024). Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer’s disease. Bioorganic Chemistry, 143, 107010. https://doi.org/10.1016/j.bioorg.2023.107010

Vancouver

Wang N, Jia W, Wang J, Yang Z, Liu Y, Huang D, et al. Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer’s disease. Bioorganic Chemistry. 2024;143:107010. doi:10.1016/j.bioorg.2023.107010

BibTeX
@article{Wang2024,
  author = {Wang, Ningwei and Jia, Wenlong and Wang, Junqin and Yang, Zejun and Liu, Yaoyang and Huang, Dehua and Mei, Xiaohan and Xiong, Xinxin and Shi, Jing and Tang, Yadong and Chen, Guang and Di, Donghua and Hou, Yunlei and Liu, Yajing},
  title = {Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer’s disease},
  journal = {Bioorganic Chemistry},
  year = {2024},
  volume = {143},
  pages = {107010},
  doi = {10.1016/j.bioorg.2023.107010}
}
Kostenlos starten →